LevelsRx review
Plan rungs render blank
Compounded semaglutide starts at $150 a month, but the one-, three-, six- and twelve-month rungs behind that figure print as an empty dollar sign.
Our verdict
LevelsRx puts three compounded products on its home page with a starting price on each, then builds product pages where the price field is empty. The Wegovy, Zepbound and Ozempic pages each render four plan tabs, and every tab shows a bare dollar sign next to a slash-mo. The compounded products have no detail page at all, so $150 for semaglutide and $240 for tirzepatide are the only figures a buyer can read. The FAQ states there are no hidden fees, membership costs or lab charges, which makes those starting figures clean as far as they go. How far they go is the problem, because the plan ladder appears only after an onboarding flow that opens by asking for height and weight.
Disclosure: GLP Loss is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
At a glance
- Category
- GLP-1 pricing
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Rises with dose
- From
- $150/mo
- Dose published
- No
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Pharmacy
- RedRock · Health Warehouse · Precision Medicine · Triad Rx
- LegitScript
- Claimed by provider
- Updated
- September 2026
What it is
An online GLP-1 weight-loss program selling compounded semaglutide and tirzepatide, with a separate branded page offering Wegovy and Zepbound.
How it works
An eligibility quiz, then either a video visit or, depending on the state, a prescription fill without one. Payment comes before the health-history intake form is completed. Unlimited video calls with clinicians, a member community, free home delivery and guaranteed on-time refills are all listed as included.
Pricing transparency
Compounded semaglutide starts at $150 a month as a weekly injection, compounded tirzepatide at $240, and an oral liposomal semaglutide dropper at $150. The branded page prices Wegovy and Zepbound from $1,200 a month each, and the FAQ adds that brand-name pricing depends on insurance coverage. Every product page offers one-, three-, six- and twelve-month plans with Best Value marked on the one-month tab, and each of those tabs renders a dollar sign with nothing after it. The FAQ states the subscriptions carry no hidden fees, membership costs or lab charges, and that charges appear on a card statement as OPNLP LEVELSRX.
Branded vs compounded
Compounded semaglutide and compounded tirzepatide as weekly injections, plus an oral liposomal semaglutide taken by dropper. Compounded drugs are not FDA-approved and are not reviewed by the FDA for safety, efficacy or quality before dispensing. Branded Wegovy and Zepbound sit on a separate page and are not compounded. LevelsRx states it does not manufacture compounded medications and names no pharmacy.
Pros and watch-outs
What we like
- No membership fee, lab charge or hidden fee stated
- Oral dropper priced level with the weekly injection
- Branded Wegovy and Zepbound offered on their own page
- LegitScript certification displayed on the site
Watch-outs
- Plan prices render as an empty dollar sign
- Compounded products have no detail page
- The plan ladder appears only after an intake
- No milligram strength published anywhere
Best for
Buyers comparing oral and injected semaglutide.
Who should look elsewhere
Anyone who needs the plan ladder before signing up.
How LevelsRx compares
A few alternatives worth a look, depending on what you’re optimizing for.
- SkinnyRx
A tirzepatide price you can check
See SkinnyRx → - Shed
Compounded pricing without a membership
See Shed → - RxSpan MD
Comparing plan terms upfront
See RxSpan MD →
More GLP-1 sellers by price reviews: Strut HealthWellorithmWillowYourEraMyDrHank1st Optimal
Evidence & trials · Last updated September 2026
How we assessed this. This review reflects GLP Loss’s own read of LevelsRx’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- What does LevelsRx cost?
- Compounded semaglutide and the oral liposomal dropper each start at $150 a month, and compounded tirzepatide starts at $240. Those are starting figures rather than settled rates. The one-, three-, six- and twelve-month plan prices show as an empty dollar sign on every product page.
- Are there membership or lab fees?
- The FAQ states the subscriptions include comprehensive coaching and services with no hidden fees, membership costs or lab charges. Regular virtual consultations, prescription management, nutritionist coaching and chat support are listed inside the price. Charges appear on a card statement as OPNLP LEVELSRX.
- Does LevelsRx sell branded medication?
- Yes, on a separate page. Wegovy and Zepbound are each listed from $1,200 a month, and the FAQ adds that brand-name pricing depends on insurance coverage. Those two are FDA-approved products rather than compounded preparations, and they are priced eight times above the compounded line.
- Is there an oral option?
- Yes. An oral compounded semaglutide is sold as a liposomal liquid taken by dropper, starting at $150 a month, the same figure as the weekly injection. It is presented as the route for patients who want a GLP-1 without needles.
- Is LevelsRx expensive compared with other GLP-1 providers?
- LevelsRx is listed from $150/mo in this comparison. The 387 reviewed GLP-1 providers with a listed monthly starting amount range from $76 to $1299, with a median of $179. That puts LevelsRx below the median. The comparison excludes 192 other reviewed GLP-1 providers. Medicines, doses and payment commitments differ. Confirm the medication, renewal charge and included visits, supplies and delivery before deciding.